
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts
Ungaro, Ryan C, Limketkai, Berkeley N, Jensen, Camilla Bjørn, Allin, Kristine Højgaard, Agrawal, Manasi, Ullman, Thomas, Colombel, Jean-Frederic, Jess, TineLangue:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2018-317021
Date:
November, 2018
Fichier:
PDF, 866 KB
english, 2018